Parexel | Sustainability Performance
Manufactures construction materials, including mortars, facades, and adhesives.
1982
United States
10,001+ employees
Pharmaceuticals
$1B - 10B in revenue
$100M - 500M in profitability
Sustainability Ranking & Industry Benchmark
#4579
Overall#982
in United States#107
in PharmaceuticalsSustainability Maturity
Sustainability Intent
Overview
Environmental
Energy consumptionGovernance
Targets
Renewable energy
Critical
Renewable electricity
Reveal data for 1 credit
19%2022
Industry rank: 15 out of 312
Total electricity consumption
and % renewables
(MWh, % of consumption)
Industry rank: 15 out of 312
Total electricity
Share of renewable electricity
Industry benchmark
Controversy level
- Parexel International has faced multiple US FDA Form 483 observations at clinical trial sites including the historic 2018 Massachusetts trial enrollment scandal, plus class actions over inadequate disclosure of pharmaceutical customer pipeline before the 2021 EQT acquisition.
Sustainability targets and commitments
Reveal data for 1 credit
| Target | Year | Value | Scope | Baseline |
|---|
